User:Mattatnotch/sandbox

Albany Molecular Research, Inc. (AMRI) is a global contract research and manufacturing organisation that provides customers with fully integrated drug discovery, development, and manufacturing services. AMRI supplies services and technologies that support the discovery and development of pharmaceutical products and the manufacturing of API and drug product for existing and experimental new drugs. AMRI operates locations in the United States, Europe, and Asia.

History
Founded in 1991 as Albany Molecular Research, Inc prodiving a fee-for-service contract services platform that included drug discovery, development and manufacturing and an independent R&D division

In 2007 AMRI acquired two plants and land for expansion in Aurangabad and Navi Mumbai, India for a fee of approximately $11 million.

In Feburary 2010 AMRI acquired Excelsyn for $19 million and took control of their manufacturing site in Wales

In June 2010, AMRI acquired Hyaluron Inc for approximately $27 million.

In January 2011, AMRI announced the merging of its Discovery R&D and Discovery Chemistry departments to form a Global Drug Discovery organization.

In May 2012 AMRI launched a rebranding campaign under the title SMARTSOURCING under the tagline "Pharma has discovered a new world".

Drug Discovery
At the earliest stages of drug discovery, AMRI helps customers identify and optimize biologically active compounds using both natural product-based and synthetic chemical libraries, along with in vitro biology capabilities. Once a lead compound is identified, AMRI provides medicinal chemistry and lead optimization coupled with technologies in metabolism and biotransformation.

Development
AMRI provides a variety of key development services to help move compounds into clinical trials including chemical process R&D, pre-formulation, formulation development, analytical development, separation sciences, bioanalytical services and scale-up.

cGMP Manufacturing
AMRI’s manufacturing facilities are strategically situated in various locations across the United States, UK and Asia. These locations are globally positioned to provide tailored customer solutions and enable the efficient and cost-effective transfer of pre-clinical, clinical, and commercial drug products from small-scale to large-scale production.

Aeseptic Fill and Finish
AMRI provides process scale-up development and aseptic filling services for projects ranging from preclinical to clinical to commercial.


 * Syringe, vial and custom container filling capabilities
 * Lyophilization services and vials
 * Stability Optimization Services (SOS)

Project Management
AMRI conducts a six stage project management process. After agreeing a CDA (Confidential Disclosure Agreement) AMRI chemists evaluate the technical solutions available to the client. AMRI then assess each project in terms of its complexity, scaleability, likely batch strategy and other considerations. AMRI gathers a group of top experts in the company at this stage to identify key issues and come up with ideas for progression, regardless of who the final project manager will be. After that AMRI creates a proposal, focussing on shortening timelines, improving yields and quality and reducing costs. Having created a proposal AMRI assign a project team, lead by a designated Project Manager. Upon project competion AMRI conduct a review of the project and request and receive customer feedback.

Locations

 * AMRI Albany (West Campus)
 * AMRI Albany (East Campus)
 * AMRI Renssellaer
 * Bothell Research Centre
 * AMRI Burlington
 * Syracuse Research Centre
 * Singapore Research Centre
 * AMRI UK
 * Hyderabad Research Centre
 * AMRI India pvt.